Back to Screener

Healthcare

Monte Rosa Therapeutics, Inc.(GLUE)

Live Price

Offline

$21.72

+4.17% today

1Y Change

+291.40%

Window

Jun 25, 2025 โ†’ Jun 22, 2026

Market Cap
$1.23B
Revenue Growth
+63.5%
EPS Growth
+53.1%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 25, 2025 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Monte Rosa Therapeutics, Inc. (GLUE) is a Healthcare stock with a market cap of $1.23B and listed on NASDAQ. The stock last traded around $21.72 and up 291.4% across the available one-year price window (Jun 25, 2025 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of +63.5%, EPS growth of +53.1%, a dividend yield of 0.0%. What stands out right now is revenue +63.5%, EPS +53.1%, free cash flow -172.3% with operating margin -43.8% and ROIC -13.6%. Valuation already assumes a fairly strong business story at price/sales 10.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines GLUE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GLUE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GLUE

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

GLUE Max Drawdown

-41.84%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GLUE and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.35
โ€”
โ€”
Est 13542.9B
โ€”
May 14
โ€”
Mar 17, 26
โœ—
-0.54
Est -0.35
-53.6%
2800.0B
Est 15554.7B
-82.0%
Mar 17
โ€”
Nov 6, 25
โœ“
-0.33
Est -0.37
+9.9%
12768.0B
Est 15506.0B
-17.7%
Nov 6
โ€”
Aug 7, 25
โœ“
-0.15
Est -0.38
+60.2%
23194.0B
Est 7773.4B
+198.4%
Aug 7
โ€”
May 8, 25
โœ“
0.57
Est -0.00
+21690.9%
84929.0B
Est 13566.7B
+526.0%
May 8
โ€”
Mar 20, 25
โœ“
0.23
Est 0.02
+1379.1%
60647.0B
Est 46667.8B
+29.9%
Mar 20
โ€”
Nov 7, 24
โœ“
-0.29
Est -0.49
+40.8%
9216.0B
Est 2638.1B
+249.3%
Nov 7
โ€”
Aug 8, 24
โœ“
-0.43
Est -0.54
+20.4%
4695.0B
Est 1348.9B
+248.1%
Aug 8
โ€”
May 9, 24
โœ“
-0.53
Est -0.57
+7.0%
1064.0B
Est 1400.0B
-24.0%
May 9
โ€”
Mar 14, 24
โœ—
-0.58
Est -0.33
-75.8%
โ€”
Est 3527.8B
โ€”
Mar 14
โ€”
Nov 9, 23
โœ“
-0.70
Est -0.72
+2.8%
โ€”
Est โ€”
โ€”
Nov 9
โ€”
Aug 10, 23
โœ—
-0.71
Est -0.70
-1.4%
โ€”
Est โ€”
โ€”
Aug 10
โ€”
May 11, 23
โœ“
-0.65
Est -0.68
+4.4%
โ€”
Est โ€”
โ€”
May 11
โ€”
Mar 16, 23
โœ—
-0.63
Est -0.62
-1.6%
โ€”
Est โ€”
โ€”
Mar 16
โ€”
Nov 10, 22
โœ“
-0.58
Est -0.60
+3.3%
โ€”
Est โ€”
โ€”
Nov 10
โ€”
Aug 11, 22
โœ—
-0.57
Est -0.54
-5.6%
โ€”
Est โ€”
โ€”
Aug 11
โ€”
May 11, 22
โœ“
-0.51
Est -0.52
+1.9%
โ€”
Est โ€”
โ€”
May 11
โ€”
Mar 29, 22
โœ—
-0.93
Est -0.50
-86.0%
โ€”
Est โ€”
โ€”
Mar 29
โ€”
Nov 10, 21
โœ“
-0.43
Est -0.44
+2.3%
โ€”
Est โ€”
โ€”
Nov 10
โ€”
Aug 12, 21
โœ—
-3.63
Est -0.40
-807.5%
โ€”
Est โ€”
โ€”
Aug 12
โ€”
Jun 25, 21
-0.29
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 25
โ€”
Dec 31, 20
-0.90
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 20
-0.30
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 20
-0.25
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 20
-0.20
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener